The evaluation and structure-activity relationships of 2-benzoylaminobenzoic esters and their analogues as anti-inflammatory and anti-platelet aggregation agents

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 6, 2007, Pages 1812-1817

  Hsieh, Pei Wen ^a   Hwang, Tsong Long ^b   Wu, Chin Chung ^a   Chiang, Shin Zan ^a   Wu, Chung I ^a   Wu, Yang Chang ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

2 Benzoylaminobenzoic esters; Anti inflammatory; Anti platelet aggregation agents

Indexed keywords

2 BENZOYLAMINOBENZOIC ACID; ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ANTITHROMBOCYTIC AGENT; BENZOIC ACID ESTER DERIVATIVE; LEUKOCYTE ELASTASE; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SCREENING; DRUG SELECTIVITY; DRUG SYNTHESIS; ENZYME ASSAY; HUMAN; HUMAN CELL; IC 50; NONHUMAN; STRUCTURE ACTIVITY RELATION; THROMBOCYTE AGGREGATION INHIBITION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; ASPIRIN; BENZOATES; ESTERS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROTEINASE INHIBITORY PROTEINS, SECRETORY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STRUCTURE-ACTIVITY RELATIONSHIP; SUPEROXIDES;

EID: 33847056962     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.12.038     Document Type: Article

References (19)

1. Hankey G.J., and Eikelboom J.W. Med. J. Aust. 178 (2003) 568
2. Nathan C. Nat. Rev. Immunol. 6 (2006) 173
3. Borregaard N. Eur. J. Haematol. 41 (1998) 401
4. Ross D., Van Bruggen R., and Meischl C. Microb. Infect. 5 (2003) 1307
5. Witko-Sarsat V., Rieu P., Descamps-Latscha B., Lesavre P., and Halbwachs-Mecarelli L. Lab. Invest. 80 (2000) 617
6. Hwang T.L., Hung H.W., Kao S.H., Teng C.M., Wu C.C., and Cheng S.J. Mol. Pharmacol. 64 (2003) 1419
7. Chang F.R., Wu C.C., Hwang T.L., Patnam R., Kuo R.Y., Wang W.Y., Lan Y.H., and Wu Y.C. Arch. Pharmacol. Res. 26 (2003) 511
8. Hsieh P.W., Hwang T.L., Wu C.C., Chang F.R., Wang T.W., and Wu Y.C. Bioorg. Med. Chem. Lett. 15 (2005) 2786
9. Wu C.C., Wang T.W., Wang W.Y., Hsieh P.W., and Wu Y.C. Eur. J. Pharmacol. 527 (2005) 37
10. Kurosaki F., and Naishi A. Phytochemistry 22 (1983) 669
11. Ponchet M., Favre-Bonvin J., Hauteville M., and Ricci P. Phytochemistry 27 (1988) 725
12. Hauteville M., Ponchet M., Ricci P., and Favre-Bonvin J. J. Heterocycl. Chem. 25 (1988) 715
13. Kirino O., Yamamoto S., and Kato T. Agric. Biol. Chem. 44 (1980) 2149
14. Fenton G., Newton C.G., Wyman B.M., Bagge P., Dron D.I., David R., and Graham D.J. J. Med. Chem. 32 (1989) 265
15. Ogita H., Isobe Y., Takaku H., Sekine R., Goto Y., Misawa S., and Hayashi H. Bioorg. Med. Chem. Lett. 11 (2001) 549
16. + (4).
17. + (2).
18. Antiplatelet aggregation assays: see. Wu C.C., Wang W.Y., Kuo R.Y., Chang F.R., and Wu Y.C. Eur. J. Pharmacol. 483 (2004) 187
19. Superoxide anion formation and elastase release: see. Hwang T.L., Hung H.S., Kao S.H., Teng C.M., Wu C.C., and Cheng S.J.S. Mol. Pharmacol. 64 (2003) 1